Dolby Laboratories Inc. Class A
John D Couling (SVP, Entertainment) sells DLB shares
About this filing
Dolby Laboratories Inc. Class A (DLB) filed Form 4 (insider transaction) with the SEC on Oct 5, 2026. Form 4 reports a company insider’s trades in the company’s shares.
Key facts
- Insider
- John D Couling · SVP, Entertainment
Rule 10b5-1 plan
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +7,667 | $45.50 | $348,848.50 | 174,470 | Direct |
| Oct 1, 2026 | S · open-market saleFootnotes F2, F1 | −6,831 | $58.72 | $401,091.73 | 167,639 | Direct |
| Oct 1, 2026 | S · open-market saleFootnotes F3, F1 | −836 | $59.33 | $49,597.79 | 166,803 | Direct |
| Oct 1, 2026 | M · exercise or conversion of a derivativeEmployee Stock Option (Right to Buy)Footnotes F4 | −7,667 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Shares held following the reported transactions include 103,190 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
- F2 The shares were sold in multiple transactions at prices ranging from $58.275 to $59.255, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3 The shares were sold in multiple transactions at prices ranging from $59.32 to $59.41, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- F4 This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.
More DLB filings
- 10-K
Filed Nov 17, 2026
- 8-K
Filed Nov 17, 2026
- 8-K
Filed Nov 13, 2026
- SC 13G
Filed Oct 27, 2026
- 4
Filed Oct 2, 2026
- 144
Filed Oct 1, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.